| Molecular formula | C78H123N23O23S2 |
|---|
| Molecular weight | 1815.1 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 71300630 |
|---|
What AOD-9604 Is
AOD-9604 is a synthetic peptide compound identified in chemical databases under PubChem CID 71300630, with a molecular formula of C78H123N23O23S2. It has no FDA-approved label, no approved brand name, and no approved indication. AOD-9604 is classified as an unapproved research compound, meaning any use outside of a controlled research setting is not supported by regulatory review.
Trial Footprint
Publicly registered clinical trial records for AOD-9604 currently number zero in the dataset reviewed. No individual trial records were available to summarize. The absence of registered trials means there is no clinical trial evidence base to reference for this compound at this time.
FAQ
No. AOD-9604 has no FDA-approved label, no approved brand name, and no approved indication. It is classified as an unapproved research compound.
AOD-9604 is a synthetic peptide with the molecular formula C78H123N23O23S2. It is catalogued in PubChem under CID 71300630.
The dataset reviewed shows zero registered clinical trials for AOD-9604. This means there is currently no clinical trial evidence base available for this compound.
No side effect or adverse event reporting data was available for AOD-9604 in the dataset reviewed. Without an approved label or reported data, no side effect profile can be described.
AOD-9604 has no approved use for any purpose, as it lacks FDA approval and an approved label. Its status as an unapproved research compound means it has not undergone the regulatory review needed to establish safety or effectiveness for any use.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 71300630 ChEMBL ClinicalTrials.gov
Updated 2026-09-19